Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress of delivery methods for CRISPR-Cas9
Wu Yang, Jiaqi Yan, Pengzhen Zhuang, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 8, pp. 913-926
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Yimin Du, Yanfei Liu, Jiaxin Hu, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100854-100854
Open Access | Times Cited: 35
Biomaterial‐based gene therapy
Yi Yu, Yijun Gao, Liming He, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 33
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Zhenhai Zeng, Siheng Li, Xiuhong Ye, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 5
CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology
Darakhshan Javaid, Shahid Yousuf Ganie, Younis Ahmad Hajam, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 12, pp. 12133-12150
Open Access | Times Cited: 22
Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases
Simone Pinto Carneiro, Antonietta Greco, Enrica Chiesa, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 4, pp. 471-487
Open Access | Times Cited: 13
Recent advances and current status of gene therapy for epilepsy
Aojie Cai, Kai Gao, Fan Zhang, et al.
World Journal of Pediatrics (2024) Vol. 20, Iss. 11, pp. 1115-1137
Closed Access | Times Cited: 3
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
Mariona Pont, Marta Marqués, Maria Alba Sorolla, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4364-4364
Open Access | Times Cited: 8
Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment
Mengmeng Li, Fenglei Chen, Qian Yang, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 2
CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance
Muhammad Shahzad Rafiq, Muhammad Abubakar Shabbir, Ahmed Raza, et al.
BioDrugs (2024) Vol. 38, Iss. 3, pp. 387-404
Closed Access | Times Cited: 2
Role of CRISPR/Cas9 based therapy in breast cancer: a future direction
Asim Asrar, Deepika Gupta, Pooja Sharma, et al.
The Nucleus (2024) Vol. 67, Iss. 1, pp. 251-261
Closed Access | Times Cited: 2
Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases
Lanjie Lei, Wenjie Pan, Xin Shou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer
Nihar Godbole, Alexander Quinn, Flavio Carrión, et al.
Seminars in Cancer Biology (2023) Vol. 96, pp. 64-81
Closed Access | Times Cited: 7
Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle Peptides
Meihui Luo, Jia Ma, Xue Cheng, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 15-16, pp. 705-718
Closed Access | Times Cited: 6
How to detect CRISPR with CRISPR – employing SHERLOCK for doping control purposes
Alina Paßreiter, Nana Naumann, Andreas Thomas, et al.
The Analyst (2022) Vol. 147, Iss. 23, pp. 5528-5536
Closed Access | Times Cited: 10
Functionalization of and through Melanin: Strategies and Bio-Applications
Alexandra Mavridi‐Printezi, Arianna Menichetti, Dario Mordini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9689-9689
Open Access | Times Cited: 5
A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
Akram Hosen, Md Nakibul Hasan Nishat, MD. Mohaimin Hossain Soaib, et al.
Nano Select (2024)
Open Access | Times Cited: 1
Characterization of NiCas12b for In Vivo Genome Editing
Yunqian Zhang, Jingjing Wei, Hongyan Wang, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Nanoformulation of Peptides for Pharmaceutical Applications: In Vitro and In Vivo Perspectives
Bhargavi Ram Thimmiah, Ben Chien, Siaw Fui Kiew, et al.
Applied Sciences (2022) Vol. 12, Iss. 24, pp. 12777-12777
Open Access | Times Cited: 8
Antimicrobial resistance expansion in pathogens: a review of current mitigation strategies and advances towards innovative therapy
Martins Ajibade Adefisoye, Ademola O. Olaniran
JAC-Antimicrobial Resistance (2023) Vol. 5, Iss. 6
Open Access | Times Cited: 4
Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system
Zaid Saad Madhi, Mohammed Ali Shallan, Abdulhusein Mizhir Almaamuri, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 78, pp. 103948-103948
Closed Access | Times Cited: 5
CRISPR workflow solutions: Cargos and versatile delivery platforms in genome editing
Ahmad Munir, Muhammad Amjad Ali, Sameer H. Qari, et al.
Elsevier eBooks (2024), pp. 67-90
Closed Access
Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy
Kuirong Mao, Huizhu Tan, Xiuxiu Cong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 642-656
Open Access
A biodegradable lipid nanoparticle delivers a Cas9 ribonucleoprotein for efficient and safe in situ genome editing in melanoma
Xiaopeng Yang, Shiming Zhou, Jingyi Zeng, et al.
Acta Biomaterialia (2024)
Closed Access
Revolutionizing animal husbandry: Breakthroughs in gene editing delivery systems
Yuan Liu, Xue Bai, Xue Feng, et al.
Gene (2024), pp. 149044-149044
Closed Access
Page 1 - Next Page

Scroll to top